HOWL
Werewolf Therapeutics Inc
$2.05
Earnings Summary
Net Profits | $-5.1Mn |
Highlights
Net Profits:
Werewolf Therapeutics Inc’s net profit jumped 65.07% since last year same period to $-5.1Mn in the Q2 2023. On a quarterly growth basis, Werewolf Therapeutics Inc has generated 57.45% jump in its net profits since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Werewolf Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.36 |
EPS Estimate Current Year | -0.36 |
Highlights
EPS Estimate Current Quarter:
Werewolf Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.36 - a 18.51% jump from last quarter’s estimates.
EPS Estimate Current Year:
Werewolf Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.36.
Key Ratios
Key ratios of the Werewolf Therapeutics Inc post its Q3 2023 earnings
Earning Per Share (EPS) | 0 |
Highlights
Earning Per Share (EPS):
Werewolf Therapeutics Inc’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2023. This indicates that the Werewolf Therapeutics Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-08-10 | -0.45 | 0 | 100% |
2023-11-09 | -0.36 | 0 | 100% |
2023-05-11 | -0.59 | 0 | 100% |
₹0 US Stocks a/c Opening Fee